SummitTX Capital »

Avalo Therapeutics Ord shares owned by SummitTX Capital

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 196k 18.16

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Shs (ASML)
Eli Lilly & Co. (LLY)
MKS Instruments (MKSI)
Wal-Mart Stores (WMT)
Paypal Holdings (PYPL)
Applied Materials (AMAT)
Amazon (AMZN)
Anthem (ELV)
Costco Wholesale Corporation (COST)
UnitedHealth (UNH)
Meritage Homes Corporation (MTH)

View all positions for SummitTX Capital

Top funds holding Avalo Therapeutics Ord

BVF
Nantahala Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
RA Capital Management
Point72 Asset Management
Silverarc Capital Management
Marshall Wace
Citadel Advisors
Commodore Capital
TCG Crossover Management
UBS Group

View all funds holding Avalo Therapeutics Ord